Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lulu K Lee, Amir Goren, Natalie N Boytsov, Craig F Donatucci & Kevin T McVary. (2016) Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations. Patient Preference and Adherence 10, pages 1205-1215.
Read now
Read now
Articles from other publishers (2)
Antonio La Torre, Caterina Palleria, Irene Tamanini, Andrea Scardigli, Tommaso Cai, Manuela Colosimo, Lucia Muraca, Vincenzo Rania, Davida Mirra, Alessandro Casarella, Gianmarco Marcianò, Giovambattista De Sarro & Luca Gallelli. (2021) Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors. Uro 1:3, pages 82-98.
Crossref
Crossref
M. Gacci. (2013) Tadalafil Monotherapy for Benign Prostatic Hyperplasia. Urologia Internationalis 91:4, pages 487-488.
Crossref
Crossref